Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VRDN · against 342 other Healthcare companies of similar size
Ranked #29 of 343 · scores higher than 92% of peers · safety percentile 92
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)35 peers with a safety percentile of 90–100, including VRDN · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 329 reported | 0.37× | 0.23× | 37% | 33% | |
| BetaLower is better · 328 reported | 0.96 | 0.55 | 28% | 33% | |
| Current ratioHigher is better · 330 reported | 16.95× | 2.88× | 94% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 2 | 1.5B USD | 100 | 44 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 1.8B USD | 99 | 42 | |
| 25 | 1.5B USD | 93 | 39 | |
| 26 | 15.6B DKK (≈$2.3B) | 93 | 96 | |
| 27 | 1.8B USD | 93 | 79 | |
| 28 | 3.8B USD | 92 | 48 | |
| 29 | 2.8B USD | 92 | 51 | |
| 30 | 2.3B USD | 92 | 26 | |
| 31 | 5.4B USD | 91 | 38 | |
| 32 | 1.8B USD | 91 | ||
| 33 | 3.1B USD | 90 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score